India accounts for 1 in 7 adults living with diabetes globally. An estimated 89.8 million adults aged 20-79 years in India ...

Combining insulin treatment with the investigational drug dapagliflozin may improve health outcomes for adolescents with type ...

Combining insulin treatment with the investigational drug dapagliflozin may improve health outcomes for adolescents with type 1 diabetes, according to ...

A new clinical trial shows that combining dapagliflozin with insulin improves kidney health and blood sugar control, and ...

Participants were randomly assigned to receive either dapagliflozin 10 mg daily or placebo for 12 months. Patients were ...

I have low serum cholesterol but a high coronary calcium score, and I was told to take magnesium supplements to bring my ...

On 21 July 2025, the Court of Appeal delivered a significant ruling in AstraZeneca AB & Anor v Generics (UK) Limited & Ors, ...

A settlement between Philips and Transsion and a loss for AstraZeneca in the UK were also among the top talking points ...

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy ...

Yet, even as we celebrate these strengths, it is clear that the next phase of growth will not be driven by volume alone. To remain globally competitive and meet the complex health needs of the future, ...

(Alliance News) - AstraZeneca PLC on Monday said a test of its baxdrostat drug showed a "meaningful reduction" in hypertension. The Cambridge, England-based pharmaceutical and biotechnology firm ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.